Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Fanucci, , Alessio,
DOB:	12-SEP-1964 (Age: 61)
Gender:	male
Address:	Incrocio Combi, 822 33015 Moggio Udinese (Italy)
ID:	4754-874768-3 (ECI)

Report
Date:	05-MAY-2025

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Ambulatori 33011 Artegna (Italy)

Specimen
Collected:	05-MAY-2025

Chemistry

Test	05-MAY-2025	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.0	4 - 6	%
Glucose [Mass/volume] in Blood	76.1	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	18.9	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.9	0.9 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.4	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	136.5	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.3	3.5 - 5	mmol/L
Chloride [Moles/volume] in Blood	104.3	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	20.4 L	22 - 32	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	214.9 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	141.2	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	159.3 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	27.4 L	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows borderline elevated HbA1c, suggesting possible impaired glucose tolerance. Lipid profile reveals high total and LDL cholesterol, low HDL, and normal triglycerides, indicating increased cardiovascular risk. Mildly decreased total CO₂ may suggest a mild metabolic acidosis or compensated respiratory alkalosis. Renal function, electrolytes, and glucose are within normal limits. Recommend further cardiovascular risk assessment and consideration of lifestyle or pharmacological interventions.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows borderline elevated HbA1c, suggesting possible impaired glucose tolerance. Lipid profile reveals high total and LDL cholesterol, low HDL, and normal triglycerides, indicating increased cardiovascular risk. Mildly decreased total CO₂ may suggest a mild metabolic acidosis or compensated respiratory alkalosis. Renal function, electrolytes, and glucose are within normal limits. Recommend further cardiovascular risk assessment and consideration of lifestyle or pharmacological interventions.